Deep Learning-Assisted Diagnosis of Liver Tumors Using Non-Contrast Magnetic Resonance Imaging: A Multi-Center Study
Shihui Zhen,Weizhi Luo,Zhi Yu Jiang,Yankai Jiang,Jihong Sun,Liqing Zhang,Yujun Wang,Wu Zhongyu,Yubo Tao,Ming Cheng,Yifan Wang,Zhetuo Qi,Mei Ruan,Hai Lin,Xiujun Cai
DOI: https://doi.org/10.2139/ssrn.3723304
2020-01-01
Abstract:Background: Contrast-enhanced MRI is the best imaging modality for liver tumor detection and differential diagnosis. However, it is long scan times required and has the contrast agent-associated risks. This study aims to develop and validate a deep convolutional neural network for initial diagnosis of liver tumors based on non-contrast MRI.
Methods: In total, 50418 images in enhanced MRI from 1959 patients with liver tumor in three center were enrolled. T2-weighted imaging, diffusion-weighted imaging (DWI), and multiphasic T1-weighted imaging provided input for Inception-ResNet V2 through transfer learning to generate four models for three-way classification. The models was then validated on the independent internal and two external datasets consisting of 5172 and 2916,1338 images, respectively. The diagnostic performance of non-contrast models(T2, T2+DWI) for distinguishing malignancy from benign tumors at-patient level were further evaluated in three validation sets.
Findings: Non-contrast models demonstrated similar performance for classifying liver tumors to benign, primary malignant and metastatic tumors, compared with two models based on multi-sequence or enhanced images. In the independent internal cohort, the areas under the receiver operating characteristic curves of T2+DWI model reached 0.91(95% CI,0.888–0.932), 0.873(95% CI,0.848-0.899), and 0.876 (95% CI, 0.840-0.911) for three categories, respectively. At patient-level, the sensitivities of malignant tumors gained from non-contrast models reached 98.1%, 85.7%, 87.5% respectively in three validation sets, while all specificities were almost greater than 70%.
Interpretation: This study demonstrates that based on non-contrast MRI, deep learning algorithm can correctly classify liver tumors into benign, primary malignant and metastatic tumors at image-level, and distinguish malignancy from benign with high sensitivity at patient-level, potentially reducing the number of enhanced testing to avoid side effects and financial costs.
Funding Statement: This work was supported by grants from National Natural Science Foundation of China (81827804 to X.C.).
Declaration of Interests: None.
Ethics Approval Statement: This study was approved by the independent institutional review boards of three hospitals and performed according to the Helsinki declaration. The requirement for written informed consent was exempted because of the retrospective nature of this study.